Published in J Biol Chem on October 21, 2014
Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase. Glycobiology (2016) 0.80
Emerging Roles of Heparanase in Viral Pathogenesis. Pathogens (2017) 0.75
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell (2000) 5.72
A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol (2012) 4.48
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med (1999) 4.22
Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer (2002) 3.36
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med (1999) 3.06
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest (2001) 2.98
Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol (1995) 2.21
Integral membrane heparan sulfate proteoglycans. FASEB J (1993) 1.92
Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat Methods (2008) 1.84
Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci (2004) 1.82
Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev (1996) 1.77
Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J Biol Chem (1999) 1.70
Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science (1983) 1.63
Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem (1984) 1.61
Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci (1991) 1.57
Symbol nomenclature for glycan representation. Proteomics (2009) 1.56
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul (1990) 1.55
Organ-specific heparan sulfate structural phenotypes. J Biol Chem (2009) 1.55
Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem (1998) 1.47
Significance of heparanase in cancer and inflammation. Cancer Microenviron (2011) 1.46
Heparanase: one molecule with multiple functions in cancer progression. Connect Tissue Res (2008) 1.29
Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J Cell Biol (2002) 1.26
Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH. J Exp Med (1995) 1.24
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies. FEBS J (2013) 1.24
GlycReSoft: a software package for automated recognition of glycans from LC/MS data. PLoS One (2012) 1.24
A chip-based amide-HILIC LC/MS platform for glycosaminoglycan glycomics profiling. Proteomics (2009) 1.17
Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype. J Biol Chem (2011) 1.15
Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow. Anal Chem (2010) 1.14
Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model. J Biol Chem (2001) 1.12
Human heparanase is localized within lysosomes in a stable form. Exp Cell Res (2002) 1.07
Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence. J Biol Chem (2002) 1.06
Unraveling the specificity of heparanase utilizing synthetic substrates. J Biol Chem (2010) 1.02
Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions. J Biol Chem (2011) 0.99
Characterizing the non-reducing end structure of heparan sulfate. J Biol Chem (2005) 0.99
Improved liquid chromatography-MS/MS of heparan sulfate oligosaccharides via chip-based pulsed makeup flow. Anal Chem (2011) 0.99
Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids. J Biol Chem (1997) 0.96
Deciphering mode of action of heparanase using structurally defined oligosaccharides. J Biol Chem (2012) 0.94
Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates. Glycobiology (1994) 0.87
Characterization of heparanase from a rat parathyroid cell line. J Biol Chem (2002) 0.84
Heparanase, tissue factor, and cancer. Semin Thromb Hemost (2008) 0.81